Treatment with either Rha or Met significantly reduced the pixel-based intensity of TGF-β1, Smad2, Smad3, and Smad4 with a significant increase in the pixel-based intensity of Smad7 expression compared to that of the PCOS group (P < 0.01). The gene discussed is TGFB1; the disease is polycystic ovary syndrome.